Correction to Report About Gilead Sciences' Work on a Coronavirus Drug
February 12 2020 - 1:42PM
Dow Jones News
Gilead Sciences' chief medical officer, Merdad Parsey, said a
patient's recovery after taking the company's drug could be an
anecdote. "Gilead Sciences Scrambles to Supply Experimental
Coronavirus Drug" at 10:52 a.m. ET, incorrectly quoted him saying
it could be an antidote in the fourth paragraph. (Feb. 12,
2020)
(END) Dow Jones Newswires
February 12, 2020 13:27 ET (18:27 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024